|
March 2022 NORTHWESTERN MEDICINE NEUROLOGY WELCOMES ROBIN BUERKI, MDNorthwestern Medicine is pleased to welcome Robin Buerki, MD, who joined the Neuro-oncology team January 1, 2022.
Dr. Buerki is a board-certified neuro-oncologist who graduated cum laude with an undergraduate degree from Princeton University. He then attended University of Cambridge, earning a master’s degree in immunology before obtaining his medical degree at Northwestern University Feinberg School of Medicine. Dr. Buerki completed residency training in neurology at University of Chicago and a fellowship in neuro-oncology at University of California – San Francisco. He joins Northwestern Medicine from University Hospitals Cleveland Medical Center, where he served as an assistant professor. Dr. Buerki’s clinical focus is treating patients with:
Dr. Buerki has multiple areas of interest, including:
In addition, Dr. Buerki has an interest in the adolescent and young adult (AYA) brain tumor population for whom the chronic effects of radiation can result in significant long-term neurocognitive disability. He is also interested in childhood cancer survivors for whom radiation-induced secondary malignancies can be lethal. Dr. Buerki is an active member of the Society of Neuro-oncology, American Society of Clinical Oncology, and the Neuro-oncology section of the American Academy of Neurology. His primary practice is at Northwestern Medicine Cancer Center Warrenville, which anchors the integrated Northwestern Medicine brain tumor team in the west suburbs. |
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
You May Also Like
|
|
|